- Home
- / Yiling Pharmaceutical
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Yiling Pharmaceutical financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
¥17.3
2024-10-29
Market Capitalization
¥28.5 B
2024-10-29
Revenue
¥7.7 B
FY, 2025
CreditSafe Score
?
Score changed on Jun 06, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| CNY | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 4.7B | 5.7B | 8.6B | 10.0B | 12.3B | 10.2B | 6.4B | 7.7B |
| Cost of goods sold | 1.6B | 2.1B | 3.1B | 3.7B | 4.5B | 4.4B | 3.2B | 2.8B |
| Gross profit | 3.1B | 3.6B | 5.5B | 6.3B | 7.8B | 5.8B | 3.1B | 4.9B |
| Gross profit margin, % | 63.5% | 64.0% | 63.1% | 63.2% | 56.7% | 49.3% | 63.8% | |
| Operating expense total | 2.2B | 2.7B | 3.8B | 4.4B | 4.5B | 3.6B | 3.2B | 2.7B |
| Depreciation and amortization | 249.5M | 256.3M | 293.2M | 345.4M | 521.0M | 549.6M | 604.7M | 614.3M |
| EBITDA | 906.2M | 910.6M | 1.7B | 1.9B | 3.3B | 2.2B | (13.7M) | 2.2B |
| EBITDA margin, % | 16.0% | 19.4% | 19.2% | 26.9% | 21.3% | -0.2% | 28.9% | |
| EBIT | 661.8M | 678.9M | 1.4B | 1.6B | 2.8B | 1.7B | (817.6M) | 1.6B |
| EBIT margin, % | 11.9% | 16.2% | 16.0% | 22.8% | 16.5% | -12.8% | 20.7% | |
| Interest income | 17.7M | 7.5M | 14.1M | 20.4M | 12.9M | 16.1M | 8.0M | 6.5M |
| Interest expense | 72.0K | 3.4M | 28.1M | 29.1M | 38.9M | 29.0M | 1.1M | |
| Pre tax profit | 701.0M | 707.9M | 1.4B | 1.6B | 2.8B | 1.7B | (800.2M) | 1.6B |
| Income tax expense | 108.0M | 104.8M | 207.5M | 212.1M | 423.8M | 339.9M | (66.0M) | 309.9M |
| Net Income | 593.0M | 603.0M | 1.2B | 1.3B | 2.4B | 1.3B | (734.2M) | 1.3B |